English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52183505    ???header.onlineuser??? :  743
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"ling m"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 11-31 of 31  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-02-14T02:50:22Z Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects Wen-Fang Cheng;Hung C.F.;Pai S.I.;Hsu K.F.;He L.;Ling M.;Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C.
臺大學術典藏 2020-02-14T02:50:21Z Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion Wen-Fang Cheng;Hung C.-F.;Hsu K.-F.;Chai C.-Y.;He L.;Polo J.M.;Slater L.A.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-14T02:50:18Z CD8+ T cells, NK cells and IFN-�^ are important for control of tumor with downregulated MHC class I expression by DNA vaccination Wen-Fang Cheng;Hung C.F.;Lin K.Y.;Ling M.;Juang J.;He L.;Lin C.T.;Wu T.-C.; WEN-FANG CHENG; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:47Z Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene Pardoll D.M.; WEN-FANG CHENG; Ling M.; Wu T.-C.; Chen C.-H.; Wang T.-L.; Ji H.; Hung C.-F.; Pardoll D.M.; WEN-FANG CHENG; Ling M.; Wu T.-C.; Wu T.-C.;Ling M.;WEN-FANG CHENG;Pardoll D.M.;Hung C.-F.;Ji H.;Wang T.-L.;Chen C.-H.; Chen C.-H.; Wang T.-L.; Ji H.; Hung C.-F.
臺大學術典藏 2020-02-06T05:22:47Z Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:47Z Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments Wu T.-C.;Roden R.B.S.;Slater L.A.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:46Z Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand Wu T.-C.;Ling M.;He L.;Chai C.-Y.;WEN-FANG CHENG;Hsu K.-F.;Hung C.-F.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:45Z Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:45Z Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen Wu T.-C.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:45Z Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen Wu T.-C.;Ling M.;Slater L.A.;He L.;WEN-FANG CHENG;Hung C.-F.;Hsu K.-F.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:44Z Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene Wu T.-C.;Ling M.;Rice C.M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:42Z Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects Ling M.; Wu T.C.; Wu T.C.;Ling M.;He L.;Hsu K.F.;Pai S.I.;Hung C.F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.
臺大學術典藏 2020-02-06T05:22:40Z Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion Wu T.-C.;Ling M.;Slater L.A.;Polo J.M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:39Z Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes Wu T.-C.;Lin C.-T.;Juang J.;Ling M.;He L.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:38Z CD8+ T cells, NK cells and IFN-�^ are important for control of tumor with downregulated MHC class I expression by DNA vaccination Wu T.-C.;Lin C.T.;He L.;Juang J.;Ling M.;Lin K.Y.;Hung C.F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C.; WEN-FANG CHENG; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C.
國立臺灣科技大學 2020 Laboratory and full-scale performances of integrated anaerobic granule-aerobic biofilm-activated sludge processes for high strength recalcitrant paint wastewater Show, K.-Y.;Ling, M.;Guo, H.;Lee, D.-J.
臺大學術典藏 2003 Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes Hung C.-F.;Wen-Fang Cheng;He L.;Ling M.;Juang J.;Lin C.-T.;Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C.
臺大學術典藏 2001 Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen Hung C.-F.; Chai C.-Y.; Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Ling M.; Wu T.-C.; Hsu K.-F.; He L.; Chai C.-Y.; Hung C.-F.; WEN-FANG CHENG
臺大學術典藏 2001 Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen Wu T.-C.; Ling M.; He L.; Hsu K.-F.; Chai C.-Y.; WEN-FANG CHENG; Hung C.-F.; Hung C.-F.;Wen-Fang Cheng;Chai C.-Y.;Hsu K.-F.;He L.;Ling M.;Wu T.-C.
臺大學術典藏 2001 Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand Hung C.-F.;Hsu K.-F.;Wen-Fang Cheng;Chai C.-Y.;He L.;Ling M.;Wu T.-C.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
臺大學術典藏 2001 Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments Wu T.-C.; Roden R.B.S.; Slater L.A.; Ling M.; He L.; Chai C.-Y.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; Wen-Fang Cheng;Hung C.-F.;Hsu K.-F.;Chai C.-Y.;He L.;Ling M.;Slater L.A.;Roden R.B.S.;Wu T.-C.

Showing items 11-31 of 31  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page